|Articles|April 2, 2021
Cryogenic Cold Solutions are Enhancing Vaccine Efficacy & Yields
Author(s)Air Products and Chemicals, Inc.
Paper examines how cryogenic cold-temperature solutions are gaining favor versus traditional mechanical refrigeration methods in the manufacturing, storage, and distribution of vaccines due to their enhanced efficacy, stability and yield.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
4
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
5
